Published in Am J Pathol on October 01, 2003
Satellite cells and the muscle stem cell niche. Physiol Rev (2013) 3.40
Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol (2008) 2.16
Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell (2007) 2.16
Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res (2006) 1.91
Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res (2008) 1.71
Sonic hedgehog regulates angiogenesis and myogenesis during post-natal skeletal muscle regeneration. J Cell Mol Med (2008) 1.27
Context matters: in vivo and in vitro influences on muscle satellite cell activity. J Cell Biochem (2008) 1.27
Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. Mol Biol Cell (2007) 1.26
Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther (2009) 1.25
uPA deficiency exacerbates muscular dystrophy in MDX mice. J Cell Biol (2007) 1.22
Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells. Am J Physiol Regul Integr Comp Physiol (2009) 1.13
A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease. PLoS Comput Biol (2011) 1.13
Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J (2008) 1.11
Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice. Am J Pathol (2012) 1.09
Satellite cell-mediated angiogenesis in vitro coincides with a functional hypoxia-inducible factor pathway. Am J Physiol Cell Physiol (2009) 1.07
Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury. Mol Ther (2011) 1.05
Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS One (2012) 1.00
Extracellular superoxide dismutase is a growth regulatory mediator of tissue injury recovery. Mol Ther (2008) 1.00
The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscular pathology. Am J Phys Med Rehabil (2009) 0.98
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials (2010) 0.96
Role of VEGF in organogenesis. Organogenesis (2008) 0.96
An engineered muscle flap for reconstruction of large soft tissue defects. Proc Natl Acad Sci U S A (2014) 0.95
CD34 promotes satellite cell motility and entry into proliferation to facilitate efficient skeletal muscle regeneration. Stem Cells (2011) 0.92
Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma. Sarcoma (2011) 0.92
Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor. Hum Mol Genet (2012) 0.89
Raf-induced vascular endothelial growth factor augments Kaposi's sarcoma-associated herpesvirus infection. J Virol (2004) 0.89
Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network. PLoS One (2010) 0.89
Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice. Hum Mol Genet (2010) 0.88
Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. Am J Physiol Heart Circ Physiol (2011) 0.87
Beneficial effect of mechanical stimulation on the regenerative potential of muscle-derived stem cells is lost by inhibiting vascular endothelial growth factor. Arterioscler Thromb Vasc Biol (2013) 0.86
Addition of mesenchymal stem cells enhances the therapeutic effects of skeletal myoblast cell-sheet transplantation in a rat ischemic cardiomyopathy model. Tissue Eng Part A (2014) 0.85
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications. Tissue Eng Part B Rev (2014) 0.85
The role of endothelial cells in myofiber differentiation and the vascularization and innervation of bioengineered muscle tissue in vivo. Biomaterials (2012) 0.85
VEGF improves skeletal muscle regeneration after acute trauma and reconstruction of the limb in a rabbit model. Clin Orthop Relat Res (2012) 0.84
VEGFA family isoforms regulate spermatogonial stem cell homeostasis in vivo. Endocrinology (2011) 0.84
Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment. Front Physiol (2015) 0.82
The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system. J Biol Chem (2012) 0.81
Markers of degeneration and regeneration in Duchenne muscular dystrophy. Acta Myol (2009) 0.80
Low temperatures reduce skin healing in the Jacaré do Pantanal (Caiman yacare, Daudin 1802). Biol Open (2013) 0.79
Low intensity laser therapy accelerates muscle regeneration in aged rats. Photonics Lasers Med (2012) 0.79
Sonic hedgehog therapy in a mouse model of age-associated impairment of skeletal muscle regeneration. J Gerontol A Biol Sci Med Sci (2013) 0.78
Identification, isolation and expansion of myoendothelial cells involved in leech muscle regeneration. PLoS One (2009) 0.76
Tissue engineered strategies for skeletal muscle injury. Stem Cells Int (2011) 0.75
Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors. PLoS One (2017) 0.75
Timed Delivery of Therapy Enhances Functional Muscle Regeneration. Adv Healthc Mater (2017) 0.75
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 18.26
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (1995) 15.15
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (1995) 9.84
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med (1999) 9.18
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol (1994) 7.36
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem (1991) 7.22
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Myogenic satellite cells: physiology to molecular biology. J Appl Physiol (1985) (2001) 6.27
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem (1994) 6.18
Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev (1992) 5.50
A myogenic cell line with altered serum requirements for differentiation. Differentiation (1977) 5.30
Mouse model of angiogenesis. Am J Pathol (1998) 4.28
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature (2002) 4.10
Age-dependent impairment of angiogenesis. Circulation (1999) 3.47
Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci (1999) 3.36
Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A (2000) 3.06
Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res (1994) 2.91
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest (1999) 2.86
VEGF receptor signal transduction. Sci STKE (2001) 2.75
Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol (1999) 2.74
Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology (2000) 2.51
Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol (1992) 2.47
Molecular mechanisms regulating myogenic determination and differentiation. Front Biosci (2000) 2.22
Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem (1992) 2.12
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res (2000) 2.04
Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res (2001) 1.95
VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. Development (1998) 1.94
Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem (1998) 1.89
Hormones, growth factors, and myogenic differentiation. Annu Rev Physiol (1991) 1.83
Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem (2002) 1.79
Replicating myoblasts express a muscle-specific phenotype. Proc Natl Acad Sci U S A (1988) 1.79
Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem (2000) 1.71
Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation (1999) 1.66
Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol Cell Biol (2002) 1.63
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol (2002) 1.62
Flk-1 as a target for tumor growth inhibition. Cancer Res (1996) 1.56
Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB J (2001) 1.44
Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. J Med Chem (1999) 1.41
Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol (2001) 1.34
Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res (1999) 1.30
VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg (2000) 1.23
Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo. Microcirculation (2001) 1.23
Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation (1997) 1.21
VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res (1995) 1.17
Effects of growth factors on myogenic differentiation. Am J Physiol (1989) 1.14
Coordinate regulation of cell cycle and apoptosis during myogenesis. Prog Cell Cycle Res (1997) 1.08
Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Circ Res (1999) 1.07
Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci Lett (2002) 0.98
Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation (2000) 0.95
Difference of molecular response to ischemia-reperfusion of rat skeletal muscle as a function of ischemic time: study of the expression of p53, p21(WAF-1), Bax protein, and apoptosis. Ann Plast Surg (2002) 0.94
Apoptosis in skeletal muscle. Front Biosci (2001) 0.92
Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia. Ann Thorac Surg (2000) 0.85
Paracrine and autocrine regulation of vascular endothelial growth factor during tissue differentiation in the quail. Dev Dyn (1998) 0.80
Apoptotic cell death makes a minor contribution to reperfusion injury in skeletal muscle in the rat. Eur J Vasc Endovasc Surg (2001) 0.78
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem (2008) 4.69
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (2010) 4.47
Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol (2012) 3.20
SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood (2004) 3.16
Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol (2005) 2.61
Meta-analysis of randomized trials comparing off-pump with on-pump coronary artery bypass graft patency. Ann Thorac Surg (2005) 2.37
Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res (2005) 2.32
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation (2008) 2.23
Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J (2009) 2.22
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther (2008) 2.13
Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res (2007) 2.08
Atrial fibrillation after isolated coronary surgery affects late survival. Circulation (2008) 2.02
[Off-pump coronary bypass surgery: pros and cons]. G Ital Cardiol (Rome) (2006) 1.94
An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem (2009) 1.90
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A (2008) 1.80
Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci U S A (2004) 1.79
Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J (2007) 1.76
Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res (2008) 1.75
Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation (2004) 1.73
Pivotal advances: high-mobility group box 1 protein--a cytokine with a role in cardiac repair. J Leukoc Biol (2006) 1.65
HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol (2006) 1.62
p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc Res (2009) 1.62
Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol (2009) 1.57
Surgery of left ventricular aneurysm: a meta-analysis of early outcomes following different reconstruction techniques. Ann Thorac Surg (2007) 1.54
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest (2009) 1.51
Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg (2004) 1.48
p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function. Cardiovasc Res (2004) 1.48
Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial. Eur J Heart Fail (2010) 1.45
microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther (2009) 1.45
p66ShcA modulates tissue response to hindlimb ischemia. Circulation (2004) 1.43
Long-term outcome after inflammatory abdominal aortic aneurysm repair: case-matched study. World J Surg (2003) 1.42
Functional properties of cells obtained from human cord blood CD34+ stem cells and mouse cardiac myocytes in coculture. Am J Physiol Heart Circ Physiol (2008) 1.42
Myogenic potential of adipose-tissue-derived cells. J Cell Sci (2006) 1.39
High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol (2008) 1.36
Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res (2003) 1.32
MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes (2012) 1.31
Analysis of the role of chemokines in angiogenesis. J Immunol Methods (2003) 1.30
Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ Res (2005) 1.29
p66(ShcA) and oxidative stress modulate myogenic differentiation and skeletal muscle regeneration after hind limb ischemia. J Biol Chem (2007) 1.27
Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling. Circ Res (2007) 1.24
Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression. Circ Res (2003) 1.22
MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics (2010) 1.17
HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol (2008) 1.15
Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration. Arterioscler Thromb Vasc Biol (2007) 1.14
Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA (2012) 1.13
Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord (2010) 1.13
The epicardium in cardiac repair: from the stem cell view. Pharmacol Ther (2010) 1.12
Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J (2010) 1.12
Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol (2006) 1.10
Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart. Proc Natl Acad Sci U S A (2011) 1.09
Off-pump versus on-pump coronary artery bypass: meta-analysis of currently available randomized trials. Ann Thorac Surg (2003) 1.09
Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina. PLoS One (2013) 1.09
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions. J Exp Clin Cancer Res (2008) 1.08
C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. Cardiovasc Res (2010) 1.08
Oxidative stress induces protein phosphatase 2A-dependent dephosphorylation of the pocket proteins pRb, p107, and p130. J Biol Chem (2003) 1.08
Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J Neurosurg (2002) 1.08
Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics (2009) 1.07
HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS One (2011) 1.07
The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc Res (2012) 1.07
Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy. J Am Coll Cardiol (2007) 1.07
SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway. Oncogene (2003) 1.06
Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J Gene Med (2004) 1.05
Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation. Mol Cell Biol (2007) 1.04
Different effects of high and low shear stress on platelet-derived growth factor isoform release by endothelial cells: consequences for smooth muscle cell migration. Arterioscler Thromb Vasc Biol (2002) 1.04